Clinical Trial Update: Chidamide Plus PTCy/Cyclosporine to Prevent GVHD After Myeloablative Conditioning, Matched PBSCT [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating chidamide plus post-transplant cyclophosphamide and cyclosporine to prevent graft-versus-host disease after myeloablative cond…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• Chidamide (chidamide)
• Cyclophosphamide (post-transplant) (cyclophosphamide)

Snippet

Sponsor: Sichuan University | Conditions: Leukemia, Acute, MDS | Phase 2 | Status: UNKNOWN